Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · November 10, 2023

Gastrointestinal Adverse Events and Weight Reduction in People With Type 2 Diabetes Treated With Tirzepatide

Diabetes, Obesity & Metabolism


Additional Info

Disclosure statements are available on the authors' profiles:

Diabetes, Obesity & Metabolism
Gastrointestinal adverse events and weight reduction in people with type 2 diabetes treated with tirzepatide in the SURPASS clinical trials
Diabetes Obes Metab 2023 Oct 18;[EPub Ahead of Print], H Patel, K Khunti, HW Rodbard, HS Bajaj, R Bray, Z Kindracki, Á Rodríguez

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading